When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Eli Lilly's Alzheimer's Drug Raises Hopes but Faces ... - AOL

   www.aol.com/eli-lillys-alzheimers-drug-raises...

   David Ricks, CEO of Eli Lilly, has touted the drug's potential as a groundbreaking treatment that could prevent Alzheimer's by addressing the buildup of amyloid plaques in the brain.

3. US FDA delays Lilly Alzheimer's drug decision, calls for ...

   www.aol.com/news/us-fda-delays-lilly-alzheimers...

   (Reuters) -The U.S. Food and Drug Administration has delayed its decision on Eli Lilly's experimental treatment for early Alzheimer's disease and will hold a meeting of outside experts to discuss ...

4. Eli Lilly Alzheimer's drug approved by US FDA - AOL

   www.aol.com/news/us-fda-approves-lillys...

   (Reuters) -The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second therapy for slowing progression of the brain-wasting disease ...

5. Lilly Alzheimer's drug gets unanimous backing from FDA ... - AOL

   www.aol.com/news/us-fda-advisers-review-eli...

   (Reuters) -Outside advisers to the U.S. Food and Drug Administration on Monday voted unanimously that the benefits of Eli Lilly's experimental Alzheimer's treatment donanemab outweighed its risks ...

6. FDA approves Eli Lilly’s Alzheimer’s drug Kisunla - AOL

   www.aol.com/news/fda-approves-eli-lilly...

   The Food and Drug Administration approved a new Alzheimer’s drug from Eli Lilly that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities in people with ...

7. Solanezumab - Wikipedia

   en.wikipedia.org/wiki/Solanezumab

   Solanezumab (proposed INN, LY2062430 [1]) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector [2] for patients with Alzheimer's disease. [3] [4] The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials. [5] [6]